Clinical Trial Update: Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating concomitant chemotherapy with radiotherapy and cetuximab (Erbitux) in locally advanced head and neck squamous cell carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Groupe Oncologie Radiotherapie Tete et Cou | Conditions: HNSCC | Phase 3 | Status: COMPLETED